External Defibrillator Makers Seek Guidance On Reporting Adverse Events
This article was originally published in The Gray Sheet
Executive Summary
Makers of external defibrillators to treat sudden cardiac arrest want better FDA guidance on when to report adverse events for the critical-use devices.
You may also be interested in...
FDA Advocates PMAs For Automated External Defibrillators
Automated external defibrillators may require review via the pre-market approval (PMA) route in coming years, according to a preliminary FDA assessment and advisory panel input.
FDA Advocates PMAs For Automated External Defibrillators
Automated external defibrillators may require review via the pre-market approval (PMA) route in coming years, according to a preliminary FDA assessment and advisory panel input.
FDA Seeks To Improve External Defibrillator Design, Manufacture
FDA’s newest device improvement initiative targets another widely used, lifesaving device with a history of adverse events and recalls: external defibrillators used to treat sudden cardiac arrest.